切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Mixed lineage kinase domain-like protein (MLKL) - NAE - Voltage-gated Calcium Channels (CaV) - VEGFR

56件产品中的 1-10

页面
每页
清除全部
  1. MAZ51
    C3342 MAZ51
    Target: VEGFR
    Summary: VEGFR3拮抗剂
      ≥31.4 mg/mL
      insoluble in H2O
  2. Dovitinib (TKI258) Lactate
    B5953 Dovitinib (TKI258) Lactate
    Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: 酪氨酸激酶抑制剂(TKI)
      ≥10.62 mg/mL
      ≥168.2 mg/mL
  3. Fruquintinib(HMPL-013)
    B5864 Fruquintinib(HMPL-013)
    中文名: 呋喹替尼
    Target: VEGFR
    Summary: VEGFR1\2和3抑制剂
      ≥6.35 mg/mL
      insoluble in H2O
  4. AZD2932
    B5835 AZD2932
    Target: FLT3|VEGFR|PDGFR|c-Kit
    Summary: VEGFR-2\PDGFRβ\Flt-3和c-Kit的抑制剂
      Soluble in DMSO
  5. Altiratinib
    B5832 Altiratinib
     1 Citation
    Target: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2
    Summary: c-MET/TIE-2/VEGFR抑制剂
      ≥21.55 mg/mL
      insoluble in H2O
  6. ACTB-1003
    B4904 ACTB-1003
    Target: VEGFR|FGFR|Tie-2|RSK|p70 S6K
    Summary: FGFR1抑制剂
      ≥18.15 mg/mL
      insoluble in H2O
  7. Necrosulfonamide
    B7731 Necrosulfonamide
     1 Citation
    Target: Mixed lineage kinase domain-like protein (MLKL)
    Summary: 坏死抑制剂
      ≥46.1 mg/mL
      insoluble in H2O
  8. SNX 482
    B5351 SNX 482
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: 电压依赖性R型CaV2.3钙通道阻滞剂
      Soluble in H2O
  9. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  10. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O

56件产品中的 1-10

页面
每页